Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2024 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

rhoen-klinikum ag - RHKJF

RHKJF

Close Chg Chg %
13.85 -0.60 -4.33%

Closed Market

13.25

-0.60 (4.33%)

Volume: 352.00

Last Updated:

Nov 5, 2024, 3:34 PM EDT

Trade Now

Company Overview: rhoen-klinikum ag - RHKJF

RHKJF Key Data

Open

$13.25

 Day Range

13.25 - 13.25

52 Week Range

11.15 - 13.85

 Market Cap

$0.00

Shares Outstanding

66.94M

 Public Float

3.65M

Beta

0.01

 Rev. Per Employee

N/A

P/E Ratio

0.00

 EPS

$0.73

Yield

2,185,830.00%

 Dividend

$0.16

EX-DIVIDEND DATE

Jun 8, 2023

 SHORT INTEREST

N/A

AVERAGE VOLUME

N/A

  

RHKJF Performance

No Data Available

RHKJF Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔

About rhoen-klinikum ag - RHKJF

Rhön-Klinikum AG engages in the provision of healthcare services. It operates hospitals and medical care centers that offers basic and standard, intermediate, maximum, and specialist care. It offers outpatient-inpatient basic and standard care in portal clinics and medical care centers. The company was founded by Eugen Münch in 1973 and is headquartered in Bad Neustadt an der Saale, Germany.

RHKJF At a Glance

Rhön-Klinikum AG
Schlossplatz 1
Bad Neustadt an der Saale, Bayern (Bavaria) 97616
Phone 49-9771-65-0 Revenue 1.81B
Industry Hospital/Nursing Management Net Income 41.85M
Sector Health Services 2023 Sales Growth 5.433%
Fiscal Year-end 12 / 2024 Employees 18,246
View SEC Filings

RHKJF Valuation

P/E Current 0.001
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 17.669
Price to Sales Ratio 0.409
Price to Book Ratio 0.535
Price to Cash Flow Ratio 5.723
Enterprise Value to EBITDA 11.28
Enterprise Value to Sales 0.308
Total Debt to Enterprise Value 0.297

RHKJF Efficiency

Revenue/Employee 99,098.057
Income Per Employee 2,293.771
Receivables Turnover 4.147
Total Asset Turnover 0.953

RHKJF Liquidity

Current Ratio 2.353
Quick Ratio 2.251
Cash Ratio 1.022

RHKJF Profitability

Gross Margin 8.146
Operating Margin -1.165
Pretax Margin 2.853
Net Margin 2.315
Return on Assets 2.206
Return on Equity 3.113
Return on Total Capital 2.703
Return on Invested Capital 2.783

RHKJF Capital Structure

Total Debt to Total Equity 11.967
Total Debt to Total Capital 10.688
Total Debt to Total Assets 8.421
Long-Term Debt to Equity 11.675
Long-Term Debt to Total Capital 10.427
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Rhoen-klinikum Ag - RHKJF

Collapse All in section
All values USD millions. 2020 2021 2022 2023 5-year trend
Sales/Revenue
1.74B 1.86B 1.71B 1.81B
Sales Growth
+6.70% +6.73% -7.81% +5.43%
Cost of Goods Sold (COGS) incl D&A
1.61B 1.69B 1.55B 1.66B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
79.15M 82.43M 72.03M 70.47M
Depreciation
74.36M 76.40M 66.77M 65.28M
Amortization of Intangibles
4.79M 6.03M 5.25M 5.19M
COGS Growth
+6.79% +4.56% -8.25% +7.34%
Gross Income
130.10M 173.74M 167.71M 147.30M
Gross Income Growth
+5.60% +33.54% -3.47% -12.17%
Gross Profit Margin
+7.46% +9.34% +9.78% +8.15%
2020 2021 2022 2023 5-year trend
SG&A Expense
151.01M 166.67M 146.57M 168.14M
Research & Development
- - - -
-
Other SG&A
151.01M 166.67M 146.57M 168.14M
SGA Growth
+6.69% +10.37% -12.06% +14.72%
Other Operating Expense
227.99K 236.40K 315.29K 216.22K
Unusual Expense
3.20M (1.71M) 12.25M (2.07M)
EBIT after Unusual Expense
(24.33M) 8.54M 8.57M (18.99M)
Non Operating Income/Expense
37.14M 27.47M 30.96M 74.56M
Non-Operating Interest Income
945.04K 582.72K 1.35M 11.37M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
8.43M 3.77M 4.28M 3.99M
Interest Expense Growth
+152.95% -55.22% +13.32% -6.74%
Gross Interest Expense
8.43M 3.77M 4.28M 3.99M
Interest Capitalized
- - - -
-
Pretax Income
4.38M 32.24M 35.26M 51.58M
Pretax Income Growth
-92.77% +635.47% +9.38% +46.27%
Pretax Margin
+0.25% +1.73% +2.06% +2.85%
Income Tax
1.67M (3.39M) 7.03M 8.18M
Income Tax - Current - Domestic
3.16M (2.80M) 6.29M 7.31M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(1.48M) (590.99K) 735.68K 864.89K
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
2.81M 35.73M 28.31M 43.43M
Minority Interest Expense
1.15M 2.28M 1.89M 1.57M
Net Income
1.65M 33.44M 26.43M 41.85M
Net Income Growth
-96.59% +1,921.89% -20.99% +58.38%
Net Margin Growth
+0.09% +1.80% +1.54% +2.31%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
1.65M 33.44M 26.43M 41.85M
Preferred Dividends
- - - -
-
Net Income Available to Common
1.65M 33.44M 26.43M 41.85M
EPS (Basic)
0.0247 0.4996 0.3948 0.6252
EPS (Basic) Growth
-96.59% +1,922.67% -20.98% +58.36%
Basic Shares Outstanding
66.94M 66.94M 66.94M 66.94M
EPS (Diluted)
0.0247 0.4996 0.3948 0.6252
EPS (Diluted) Growth
-96.59% +1,922.67% -20.98% +58.36%
Diluted Shares Outstanding
66.94M 66.94M 66.94M 66.94M
EBITDA
58.01M 89.26M 92.85M 49.41M
EBITDA Growth
+1.16% +53.86% +4.02% -46.78%
EBITDA Margin
+3.33% +4.80% +5.41% +2.73%

Rhoen-Klinikum Ag in the News